PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis

Michael Mahler, Jan Damoiseaux, Vera Ballet, Doreen Dillaerts, Chelsea Bentow, Jan-Willem Cohen Tervaert, Daniel Blockmans, Guy Boeckxstaens, Javier Aguilera-Lizarraga, Elena Csernok, Severine Vermeire, Xavier Bossuyt

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)E27-E30
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume56
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • anti-neutrophil cytoplasmic antibodies (ANCA)
  • inflammatory bowel disease
  • proteinase 3 (PR3)-ANCA
  • INFLAMMATORY BOWEL DISEASES
  • SEROLOGIC MARKERS
  • VASCULITIS

Cite this

Mahler, M., Damoiseaux, J., Ballet, V., Dillaerts, D., Bentow, C., Tervaert, J-W. C., Blockmans, D., Boeckxstaens, G., Aguilera-Lizarraga, J., Csernok, E., Vermeire, S., & Bossuyt, X. (2018). PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis. Clinical Chemistry and Laboratory Medicine, 56(1), E27-E30. https://doi.org/10.1515/cclm-2017-0346